Scheer Focuses on $250M Biotech Pipeline

ROCKVILLE, MD-Scheer Partners, which began focusing on the life science sector around 10 years ago in an earnest fashion, is adding another component to its roster of services. Up until recently, says founder Robert Scheer, the company has tended to focus strictly on strategic advisory services. “Our focus going forward will be those areas plus a renewed emphasis on construction and project management.” The firm will also be focusing on acquisition and development and asset and incubator management in this niche, he adds. These were all areas in which Scheer Partners has been active in the past, albeit to a limited degree.

One way in which Scheer is differentiating itself is its focus beyond the life science hub that is Gaithersburg and 1-270. “We consider the entire Greater DC area as a potential site,” Scheer says. This definition, he says, stretches from Baltimore to Danville, VA. Another differentiator is a staff that has experience in the biological and biotech areas.